Published in J Exp Med on March 01, 1986
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1986) 4.61
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med (1987) 4.53
Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci U S A (1987) 3.43
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci U S A (1987) 2.65
Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med (1989) 2.15
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor. J Exp Med (1987) 2.15
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc Natl Acad Sci U S A (1988) 1.74
Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med (1987) 1.57
Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J Cell Biol (1995) 1.52
Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology (1988) 1.48
Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med (1986) 1.40
Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways. Proc Natl Acad Sci U S A (1993) 1.39
Properties of lymph-borne (veiled) dendritic cells in culture. II. Expression of the IL-2 receptor: role of GM-CSF. Immunology (1989) 1.34
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein. J Exp Med (1988) 1.23
Reconstituted human granulocyte-macrophage colony-stimulating factor receptor transduces growth-promoting signals in mouse NIH 3T3 cells: comparison with signalling in BA/F3 pro-B cells. Mol Cell Biol (1993) 1.07
Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut (1990) 1.06
Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). Immunology (1988) 1.02
Phosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytes. Mol Biol Cell (1994) 0.99
Characterization of interleukin 2-stimulated phosphorylation of 67 and 63 kDa proteins in human T-cells. Biochem J (1987) 0.96
Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL1). J Exp Med (1989) 0.95
Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting. J Leukoc Biol (2011) 0.95
Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1. Mol Cell Biol (2001) 0.94
Transient induction of IL-2 receptor in cultured T cell lines by HTLV-1 LTR-linked tax-1 gene. EMBO J (1989) 0.91
Transmembrane signaling of interleukin 2 receptor. Conformation and function of human interleukin 2 receptor (p55)/insulin receptor chimeric molecules. J Exp Med (1987) 0.91
Distinct downstream signaling mechanism between erythropoietin receptor and interleukin-2 receptor. EMBO J (1992) 0.90
Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest (1993) 0.85
Men with low vitamin A stores respond adequately to primary yellow fever and secondary tetanus toxoid vaccination. J Nutr (2008) 0.83
Characterization of the bovine receptor(s) for interleukin-2. Immunology (1989) 0.82
Transcriptional regulation of two cytotoxic T lymphocyte-specific serine protease genes. Nucleic Acids Res (1989) 0.81
Photoaffinity labeling of ATP and NAD+ binding sites on recombinant human interleukin 2. Proc Natl Acad Sci U S A (1990) 0.79
Expression of novel interleukin 2 binding molecules and their functional roles in human B cell differentiation. J Clin Invest (1988) 0.78
Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. Br J Cancer (1996) 0.78
Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease. Br J Cancer (1990) 0.78
Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness. Clin Exp Immunol (1995) 0.78
Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes. Immunology (1990) 0.76
Evidence for two extracellular domains in the human interleukin-2 receptor: localization of IL-2 binding. EMBO J (1986) 0.76
Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes. Immunology (1990) 0.75
Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature (1979) 17.18
Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (1976) 15.73
Long term culture of tumour-specific cytotoxic T cells. Nature (1977) 14.15
Epidermal growth factor. Annu Rev Biochem (1979) 11.82
T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med (1981) 10.66
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
T-cell growth factor. Immunol Rev (1980) 8.11
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med (1984) 6.45
Functional and morphologic characterization of human T cells continuously grown in vitro. J Immunol (1977) 6.30
Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor. Proc Natl Acad Sci U S A (1978) 4.31
Interleukin 2 regulates its own receptors. Proc Natl Acad Sci U S A (1985) 4.19
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A (1985) 3.74
Receptor-mediated endocytosis of hormones in cultured cells. Annu Rev Physiol (1981) 3.56
Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res (1983) 3.44
Expression of interleukin 2 receptors on activated human B cells. J Exp Med (1984) 3.27
A novel T-cell line derived from adult T-cell leukemia. Gan (1980) 3.21
Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies. J Biol Chem (1983) 2.94
Expression of Tac antigen on activated normal human B cells. J Exp Med (1984) 2.76
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med (1984) 2.74
Local aggregation of hormone-receptor complexes is required for activation by epidermal growth factor. Nature (1979) 2.41
Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins. Curr Top Microbiol Immunol (1983) 2.32
Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation. J Biol Chem (1982) 2.03
Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A (1977) 1.97
Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature (1985) 1.90
Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer (1984) 1.89
Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody. Blood (1983) 1.65
The biology and mechanism of action of nerve growth factor. Annu Rev Biochem (1982) 1.64
Internalized insulin receptors are recycled to the cell surface in rat hepatocytes. Proc Natl Acad Sci U S A (1982) 1.63
Internalization of polypeptide hormones: mechanism, intracellular localization and significance. Diabetologia (1980) 1.49
Modulation of binding and bioactivity of insulin by anti-insulin antibody: relation to possible role of receptor self-aggregation in hormone action. Proc Natl Acad Sci U S A (1979) 1.31
Nuclear accumulation of epidermal growth factor in cultured rat pituitary cells. Nature (1980) 1.13
Retrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage. Proc Natl Acad Sci U S A (1984) 1.10
Interleukin 2 inhibits in vitro growth of human T cell lines carrying retrovirus. J Exp Med (1985) 1.08
Surface binding and internalization of platelet-derived growth factor in human fibroblasts. Proc Natl Acad Sci U S A (1983) 1.07
Dual pathways for epidermal growth factor processing after receptor-mediated endocytosis. J Cell Physiol (1982) 0.92
Intracellular distribution of nerve growth factor in rat pheochromocytoma PC12 cells: evidence for a perinuclear and intranuclear location. Proc Natl Acad Sci U S A (1980) 0.90
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem (1982) 16.71
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84
Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A (1981) 11.92
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature (1981) 9.25
Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol (1967) 8.29
Cloning of the gamma chain of the human IL-2 receptor. Science (1992) 4.50
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med (1989) 4.20
A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature (1998) 4.06
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci U S A (1991) 3.84
Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer (1988) 3.60
Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures. Proc Soc Exp Biol Med (1967) 3.45
Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science (1982) 3.37
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature (2000) 3.25
Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med (2001) 3.23
High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med (2001) 3.04
The genetic structure of natural populations of Drosophila melanogaster. IV. Heterozygous effects of radiation-induced mutations on viability in various genetic backgrounds. Genetics (1966) 2.95
A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang (1984) 2.91
Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol (1996) 2.80
Transformation of Bacillus stearothermophilus with plasmid DNA and characterization of shuttle vector plasmids between Bacillus stearothermophilus and Bacillus subtilis. J Bacteriol (1982) 2.80
Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res (1995) 2.79
Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78
PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol Cell (1998) 2.75
Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol (2001) 2.69
Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol (1996) 2.67
Pituitary apoplexy: its incidence and clinical significance. J Neurosurg (1981) 2.65
Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg (1997) 2.60
Purification and characterization of the human interleukin-18 receptor. J Biol Chem (1997) 2.58
PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol (2001) 2.52
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest (1999) 2.50
Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem (1993) 2.40
Isolation and characterization of antibiotic resistance plasmids from thermophilic bacilli and construction of deletion plasmids. J Bacteriol (1981) 2.40
Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer (1982) 2.39
Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul (1991) 2.38
A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A (2000) 2.31
B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol (1997) 2.29
Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol (1984) 2.27
Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg (2001) 2.25
The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology (2000) 2.20
Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses. J Virol (1988) 2.17
Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med (1989) 2.15
Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol (1999) 2.07
Synergistic functions of phorbol ester and calcium in serotonin release from human platelets. Biochem Biophys Res Commun (1983) 2.03
Clinical studies of cefazolin in the surgical field. Antimicrob Agents Chemother (Bethesda) (1970) 2.03
Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol (1989) 2.03
Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J Biol Chem (1997) 2.03
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. J Biol Chem (1983) 2.02
The structure of inducing factors for virginiamycin production in Streptomyces virginiae. J Antibiot (Tokyo) (1987) 1.99
A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry (1988) 1.99
Did ossification of the posterior longitudinal ligament of the spine evolve in the modern period? A paleopathologic study of ancient human skeletons in Japan. J Rheumatol (2000) 1.96
Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother (2001) 1.96
Activation of natural killer cells via the p75 interleukin 2 receptor. J Exp Med (1989) 1.95
Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer (1984) 1.89
Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J (1987) 1.88
Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol (2001) 1.87
Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood (1996) 1.85
Molecular cloning of a thermostable neutral protease gene from Bacillus stearothermophilus in a vector plasmid and its expression in Bacillus stearothermophilus and Bacillus subtilis. J Bacteriol (1983) 1.80
Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke (1998) 1.79
Interferons increase transcription of a major histocompatibility class I gene via a 5' interferon consensus sequence. Mol Cell Biol (1987) 1.78
Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg (1992) 1.77
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood (1999) 1.73
Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med (2000) 1.73
Nanosecond dynamics of the near-infrared photoluminescence of Er-doped SiO2 sensitized with Si nanocrystals. Phys Rev Lett (2006) 1.72
Increase in nucleoli after x-radiation of fibroblasts of patients with Gorlin syndrome. J Lab Clin Med (1999) 1.72
Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol (2000) 1.71
Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity (1997) 1.71
Carotid cave aneurysms of the internal carotid artery. J Neurosurg (1989) 1.65
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol (2000) 1.64
Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol (1998) 1.61
Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium (1982) 1.59
Respiratory mechanics and peripheral airway inflammation and dysfunction in asthma. Clin Exp Allergy (2013) 1.59
CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett (1999) 1.57
Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol (1984) 1.57
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia (2006) 1.56
Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol (1989) 1.55
Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus. Acta Neuropathol (1984) 1.55
Adenosine A1 receptor antagonist improves intradialytic hypotension. Kidney Int (2006) 1.54
Preoperative visualization of the artery of Adamkiewicz by intra-arterial CT angiography. AJNR Am J Neuroradiol (2007) 1.54
Electron microscopy of measles virus replication. J Virol (1969) 1.53
Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci (2001) 1.53
Prevalence of large-joint osteoarthritis in Asian and Caucasian skeletal populations. Rheumatology (Oxford) (2001) 1.52
Proteome analysis of Bacillus subtilis extracellular proteins: a two-dimensional protein electrophoretic study. Microbiology (2000) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
Postero-medial hypothalamotomy in the treatment of aggressive behaviors. Confin Neurol (1966) 1.51
Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology (2001) 1.51
Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood (1999) 1.51
Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol (2000) 1.50
A carcinoid tumor of the rectum removed by strip biopsy. Endoscopy (1993) 1.50
Quantitative in vivo measurement of thyroidal iodine content by static x-ray fluorescent technique: some preliminary clinical observations. Invest Radiol (1979) 1.49
Ulcerative colitis with skip lesions at the mouth of the appendix: a clinical study. Am J Gastroenterol (1998) 1.49
Nuclear localization of yeast Nfs1p is required for cell survival. J Biol Chem (2000) 1.48
Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol (1999) 1.48
Laboratory infection with human parvovirus B19. J Infect (1991) 1.47